Abstract
Get full access to this article
View all access options for this article.
References
1.
Roden
M.M.
,
Zaoutis
T.E.
Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005 ; 41 : 624 –53 .
2.
Petrikkos
G.
,
Skiada
A.
,
Lortholary
O.
Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012 ; 54 : S23 –34 .
3.
Spellberg
B.
,
Ibrahim
A.S.
Recent advances in the treatment of mucormycosis Curr Infect Dis 2010 ; 12 : 423 –9 .
4.
Chamilos
G.
,
Lewis
R.E.
,
Kontoyiannis
D.P.
Delaying amphotericin B-based frontline therapy significantly increased mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008 ; 47 : 503 –9 .